Implanet: Funding, Investors & Team (Sep 2026)
Implanet provide Gold Standard implants of uncompromising and indisputable quality to the various surgical markets. It is destined for healthcare professionals treating orthopedic patients. Implanet isa company that provides modern solutions (services, along with Gold Standard products) that allow healthcare professionals to improve their productivity while contributing to society's urgent need to reduce healthcare costs. They believe that today, companies can evolve in the context of globalization while being socially and economically responsible. This organisation and business model provide an unprecedented level of security and information to the healthcare community.
Implanet has raised $2.1M across 1 funding round on record, the most recent an undisclosed round of $2.1M announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Implanet Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Implanet Funding Rounds
Implanet Founders and Leadership Team
No contact details are on record for this team yet.
Implanet Funding Compared to Other Biotechnology Startups
Implanet's latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Implanet in Biotechnology and Martillac
Companies Similar to Implanet
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Implanet Funding FAQs
What does Implanet do?
Implanet provide Gold Standard implants of uncompromising and indisputable quality to the various surgical markets. It is destined for healthcare professionals treating orthopedic patients. Implanet isa company that provides modern solutions (services, along with Gold Standard products) that allow healthcare professionals to improve their productivity while contributing to society's urgent need to reduce healthcare costs. They believe that today, companies can evolve in the context of globalization while being socially and economically responsible. This organisation and business model provide an unprecedented level of security and information to the healthcare community.
How much funding has Implanet raised?
Implanet has raised $2.1M across 1 round on record. The most recent is an undisclosed round of $2.1M announced in Dec 2024.
When did Implanet last raise funding?
Implanet's most recent funding round on record is an undisclosed round of $2.1M, announced in Dec 2024.
Who founded Implanet?
FundedIQ lists Ludovic Lastennet (Founder) at Implanet.
Where is Implanet headquartered?
Implanet is based in Martillac, Aquitaine, France.
How many employees does Implanet have?
Implanet is in the 11-50 employee band.
How does Implanet's funding compare to other Biotechnology startups?
Implanet's latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Implanet Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Implanet is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.